Cardio-Oncology Drug Interactions: A Commentary With Dr Daniel Lenihan
Published: 31 Oct 2022
Dr Daniel Lenihan (The Center for Advanced Medicine, St Louis, MO, US) joins us to provide his commentary on the recently published AHA Scientific Statement for Cardio-Oncology Drug Interactions.
Dr Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure. He is the immediate past president of the International Cardio-Oncology Society.